Suppr超能文献

L-天冬酰胺酶:从一种酶分子到抗菌药物的探索需求

l-asparaginase: Need for an Expedition from an Enzymatic Molecule to Antimicrobial Drug.

作者信息

Vimal Archana, Kumar Awanish

机构信息

Department of Bioengineering, Integral University, Lucknow, UP India.

Department of Biotechnology, National Institute of Technology, Raipur, Chhattisgarh 492010 India.

出版信息

Int J Pept Res Ther. 2022;28(1):9. doi: 10.1007/s10989-021-10312-x. Epub 2021 Dec 1.

Abstract

Enzymes play a vital role in the biological system as a catalyst for biochemical reactions. They have a wide range of commercial applications in many areas like the pharmaceutical industry, food industry, etc. l-asparaginase is one of the commercial enzymes with prime importance in anticancer therapy. It is mainly used in chemotherapy; however, it has the potential to cure autoimmune disorders and infectious diseases also. Previous studies reported the antimicrobial potential of l-asparaginase. Therefore, we have discussed the possibility and challenges of the antimicrobial application of l-asparaginase in the treatment of infectious diseases. This is followed by a discussion on the effective delivery of this enzyme using biopolymeric nanocarriers that ensure safe and on target action. The present article gives a perspective on the l-asparaginase molecule that could be developed/established as an approved antimicrobial drug in the future.

摘要

酶作为生物化学反应的催化剂,在生物系统中发挥着至关重要的作用。它们在制药工业、食品工业等许多领域有着广泛的商业应用。L-天冬酰胺酶是抗癌治疗中最重要的商业酶之一。它主要用于化疗;然而,它也有治愈自身免疫性疾病和传染病的潜力。先前的研究报道了L-天冬酰胺酶的抗菌潜力。因此,我们讨论了L-天冬酰胺酶在治疗传染病中的抗菌应用的可能性和挑战。接下来讨论了使用生物聚合物纳米载体有效递送这种酶,以确保安全和靶向作用。本文对L-天冬酰胺酶分子进行了展望,该分子未来有望被开发/确立为一种获批的抗菌药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c06/8634742/900af51387f3/10989_2021_10312_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验